• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床咨询:治疗双相抑郁哪种药物最佳?

Clinical inquiries: what drugs are best for bipolar depression?

作者信息

Ukaegbu Chibuzo, Banks J Burton, Carter Nakia J, Goldman Larry S

机构信息

Department of Family Medicine, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA.

出版信息

J Fam Pract. 2008 Sep;57(9):606-8.

PMID:18786334
Abstract

Antidepressants and lamotrigine are effective. Atypical antipsychotics, lithium, and anticonvulsants also may help. Antidepressants, including tricyclics and selective serotonin reuptake inhibitors (SSRIs), are useful adjuncts in short-term treatment of bipolar depression and have low rates of inducing mania (strength of recommendation [SOR]: 1 systematic review and randomized controlled trials [RCTs]). Lamotrigine is beneficial for both acute treatment of bipolar depression and prevention of recurrent episodes (SOR: 1 systematic review and 1 RCT). Some atypical antipsychotics alone (SOR: 2 RCTs) or in combination with antidepressants (SOR: 1 multicenter RCT) effectively treat acute bipolar depression. Lithium and anticonvulsants such as valproate also may be useful (SOR: limited number of studies with small sample sizes).

摘要

抗抑郁药和拉莫三嗪是有效的。非典型抗精神病药、锂盐和抗惊厥药也可能有帮助。抗抑郁药,包括三环类药物和选择性5-羟色胺再摄取抑制剂(SSRI),是双相抑郁短期治疗中的有用辅助药物,且诱发躁狂的发生率较低(推荐强度[SOR]:1项系统评价和随机对照试验[RCT])。拉莫三嗪对双相抑郁的急性治疗和预防复发均有益(SOR:1项系统评价和1项RCT)。一些非典型抗精神病药单用(SOR:2项RCT)或与抗抑郁药联用(SOR:1项多中心RCT)可有效治疗急性双相抑郁。锂盐和丙戊酸盐等抗惊厥药也可能有用(SOR:样本量小的研究数量有限)。

相似文献

1
Clinical inquiries: what drugs are best for bipolar depression?临床咨询:治疗双相抑郁哪种药物最佳?
J Fam Pract. 2008 Sep;57(9):606-8.
2
A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.双相情感障碍患者预防复发干预措施的临床有效性和成本效益的系统评价与经济模型
Health Technol Assess. 2007 Oct;11(39):iii-iv, ix-206. doi: 10.3310/hta11390.
3
Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials.抗惊厥药物治疗躁狂是否存在类效应?来自随机临床试验的数据。
CNS Neurosci Ther. 2011 Jun;17(3):167-77. doi: 10.1111/j.1755-5949.2009.00089.x. Epub 2009 Dec 15.
4
Treatment of bipolar disorder: a systematic review of available data and clinical perspectives.双相情感障碍的治疗:现有数据及临床观点的系统综述
Int J Neuropsychopharmacol. 2008 Nov;11(7):999-1029. doi: 10.1017/S1461145708009231. Epub 2008 Aug 28.
5
Atypical antipsychotics in bipolar disorder: systematic review of randomised trials.双相情感障碍中使用非典型抗精神病药物:随机试验的系统评价
BMC Psychiatry. 2007 Aug 16;7:40. doi: 10.1186/1471-244X-7-40.
6
Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.心境稳定剂和抗精神病药物在双相情感障碍维持期的有效性:随机对照试验的系统评价
Bipolar Disord. 2007 Jun;9(4):394-412. doi: 10.1111/j.1399-5618.2007.00490.x.
7
Lamotrigine in the maintenance treatment of bipolar disorder.拉莫三嗪治疗双相情感障碍的维持治疗。
Cochrane Database Syst Rev. 2021 Sep 15;9(9):CD013575. doi: 10.1002/14651858.CD013575.pub2.
8
Antidepressants for bipolar depression: a systematic review of randomized, controlled trials.用于双相抑郁的抗抑郁药:随机对照试验的系统评价
Am J Psychiatry. 2004 Sep;161(9):1537-47. doi: 10.1176/appi.ajp.161.9.1537.
9
A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.对用于治疗双相情感障碍相关躁狂症的新型药物的临床疗效及成本效益进行快速系统评价与经济评估。
Health Technol Assess. 2004 May;8(19):iii-iv, 1-187. doi: 10.3310/hta8190.
10
Pharmacological treatments in panic disorder in adults: a network meta-analysis.成人惊恐障碍的药物治疗:网络荟萃分析。
Cochrane Database Syst Rev. 2023 Nov 28;11(11):CD012729. doi: 10.1002/14651858.CD012729.pub3.